Allopathic medicine spilled over into the economic sphere when employers and insurance companies realized how predictive genetic testing is for the probability of serious disease. However, recently, the politicals got involved into economics by legislating an ignore button on the matter. [Not to be confused with the easy button.]

A conference is scheduled on the topic next week at the The Society for Genomics Policy and Population Health (SGPPH) Spring Conference will take place on Thursday 8 May 2008 at the Birmingham Women’s Health Care NHS Trust, Edgbaston, Birmingham (UK). Continue reading →